ZHICHENG BIO
L-Leucine research directions
Why this compound has a literature
L-leucine has one of the largest single-amino-acid research literatures, for two unrelated reasons. In cell biology it is the amino acid most closely tied to the mTORC1 nutrient-sensing pathway, which gave it a structural and molecular literature separate from nutrition. In pharmaceutics it is a well-characterised excipient in spray-dried inhalation powders. Between those sits a large and contested clinical nutrition literature in older adults and in exercise science, where isolated-leucine results and combination-product results diverge.
What the literature investigates
Structural biology of leucine sensing
Leucine is unusual among dietary amino acids in having a directly characterised protein sensor. A 2016 Science paper reported the 2.7 angstrom crystal structure of Sestrin2 in complex with leucine, describing a single binding pocket that coordinates the charged functional groups and confers specificity for the hydrophobic side chain, with an enclosing loop forming a lid-latch mechanism required for binding. The authors reported that a structure-guided mutation lowering Sestrin2 affinity for leucine raised the leucine concentration required to activate mTORC1 in cells. Later work extended sensing to a zonated liver context. This literature is mechanistic and cellular, not clinical: it describes how cells detect leucine concentration, and it makes no statement about outcomes from ingesting leucine. It is nonetheless the reason leucine is discussed differently from valine and isoleucine in the primary literature.
The isolated-leucine and isolated-BCAA controversy
A 2017 critical review argued from first principles that the maximal stimulation of post-absorptive muscle protein synthesis achievable from BCAAs alone is bounded by the availability of the other essential amino acids, which in that state can only come from protein breakdown, and reported that an extensive search found no human study quantifying muscle protein synthesis after orally ingested BCAAs alone. A 2021 narrative review of isolated leucine and BCAA supplementation for strength and hypertrophy described the efficacy question as an ongoing source of controversy in sports nutrition, and a 2019 biochemical review reached a similar equivocal conclusion. A 2023 quantitative systematic review reported that ingested leucine dose was associated with the magnitude of the postprandial post-exercise muscle protein synthesis response in older adults but not in younger adults, and that no single plasma leucine variable had substantial predictive capacity. The reviews disagree in emphasis but converge on the point that isolated-leucine evidence is weaker than the ingredient's commercial prominence suggests.
Older-adult trials: isolated versus combined formulations
The clinical nutrition literature in older adults is where leucine has been tested most systematically, and it produced a clear split. A 2022 systematic review and meta-analysis of 17 randomised controlled trials in 1,418 older subjects reported no effect of leucine-isolated supplementation on total lean mass, handgrip strength or leg press, while reporting statistically significant pooled differences for handgrip strength and gait speed in the subset where leucine was combined with vitamin D. The authors described leucine-isolated supplementation as not improving muscle mass and strength in the elderly, and noted heterogeneity across trials. This is directly relevant to product architecture: the meta-analytic signal in this literature attaches to combination formats, not to leucine as a single ingredient, and pooled effect sizes even in the positive subgroups were small.
Leucine as a pharmaceutical excipient in inhalation powders
A completely separate literature treats leucine as a formulation aid rather than a nutrient. A 2021 review in Drug Discovery Today surveyed leucine as an excipient in spray-dried inhalation powders, covering its reported effects on aerosolisation and physical stability of the produced particles, the formulation and processing parameters that dictate leucine behaviour during drying, and its regulatory status. Related primary work has examined co-spray-drying with leucine or trileucine for aerosol performance and dissolution, and D-leucine microparticles have been studied for the same purpose. For a supplier this is a meaningfully different customer segment with different specification expectations, since inhalation-grade material is judged on particle engineering behaviour and impurity control rather than on nutritional assay alone.
What this means when you specify the material
Dose choices in the leucine literature cluster in two places: gram-level single doses used in acute muscle protein synthesis studies, and daily intakes in the low single grams used in older-adult trials. A 2024 indicator amino acid oxidation study in ten healthy young men placed the mean leucine requirement at 33.6 mg/kg/day (95% CI 26.2-41.0). Note also that the same study reported higher leucine intakes were accompanied by lower plasma valine and isoleucine, which is the technical basis for why blends are ratioed rather than leucine-only. For inhalation-grade enquiries, expect particle-engineering and impurity questions rather than assay-only specifications.
Cited literature
Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.
- A crystallographic study reported the 2.7 angstrom structure of Sestrin2 in complex with leucine and described a single binding pocket with a lid-latch loop; a structure-guided mutation lowering leucine affinity raised the leucine concentration needed to activate mTORC1 in cells. Saxton RA, Knockenhauer KE, Wolfson RL, et al. Science. 2016;351(6268):53-8. PMID 26586190DOI 10.1126/science.aad2087
- A critical review argued that the theoretical maximum stimulation of post-absorptive muscle protein synthesis from BCAAs alone is bounded by the supply of other essential amino acids, and reported that an extensive literature search identified no human study quantifying the muscle protein synthesis response to orally ingested BCAAs alone. Wolfe RR. J Int Soc Sports Nutr. 2017;14:30. PMID 28852372DOI 10.1186/s12970-017-0184-9
- A narrative review critically examined the acute and longitudinal literature on isolated leucine and BCAA supplementation for muscular strength and hypertrophy and described the efficacy of BCAAs as an ongoing source of controversy in sports nutrition. Plotkin DL, Delcastillo K, Van Every DW, Tipton KD, Aragon AA, Schoenfeld BJ. Int J Sport Nutr Exerc Metab. 2021;31(3):292-301. PMID 33741748DOI 10.1123/ijsnem.2020-0356
- A biochemical review examined the evidence for and against an anabolic effect of isolated branched-chain amino acid intake on muscle protein synthesis in humans and described the evidence for BCAAs alone as equivocal. Santos CS, Nascimento FEL. Einstein (Sao Paulo). 2019;17(3):eRB4898. PMID 31508659DOI 10.31744/einstein_journal/2019RB4898
- A quantitative systematic review reported that ingested leucine dose was associated with the magnitude of the postprandial post-exercise muscle protein synthesis response in older adults but not in younger adults, and that no single plasma leucine variable had substantial predictive capacity. Wilkinson K, Koscien CP, Monteyne AJ, Wall BT, Stephens FB. Physiol Rep. 2023;11(15):e15775. PMID 37537134DOI 10.14814/phy2.15775
- A systematic review and meta-analysis of 17 randomised controlled trials in 1,418 older adults reported no pooled effect of leucine-isolated supplementation on total lean mass, handgrip strength or leg press, and reported statistically significant pooled differences for handgrip strength and gait speed where leucine was combined with vitamin D. Guo Y, Fu X, Hu Q, Chen L, Zuo H. Front Nutr. 2022;9:929891. PMID 35845777DOI 10.3389/fnut.2022.929891
- An indicator amino acid oxidation study in ten healthy young adult males tested seven leucine intakes from 10 to 75 mg/kg/day and determined a mean leucine requirement of 33.6 mg/kg/day (95% CI 26.16-41.04), reporting that higher leucine intakes were accompanied by decreased plasma valine and isoleucine. Szwiega S, Pencharz PB, Xu L, et al. Am J Clin Nutr. 2024;120(5):1063-1070. PMID 39209155DOI 10.1016/j.ajcnut.2024.08.022
- A review surveyed leucine as an excipient in spray-dried inhalation powders, covering its reported effects on aerosolisation and physical stability, the formulation and processing parameters governing its behaviour during drying, and its regulatory status. Alhajj N, O'Reilly NJ, Cathcart H. Drug Discov Today. 2021;26(10):2384-2396. PMID 33872799DOI 10.1016/j.drudis.2021.04.009
Need this grade for your line?
Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.